Tamiflu, Gilead & Rumsfeld - H5N1 Captain Trips?

In 1976, a military recruit in New Jersey died from a flu that experts speculated might be the "swine flu".

At Rumsfeld's urging, the Ford administration quickly produced and distributed huge amounts of vaccine. Some batches were contaminated. 600 people sickened and 52 died. The program was stopped and nobody got swine flu.

Donald Rumsfeld was the CEO, President and then Chairman of G. D. Searle & Co., the worldwide pharmaceutical firm from 1977 to 1985. Rumsfeld is believed to have earned around US$12 million from the sale of Searle to Monsanto.

Mr. Rumsfeld, joined Gilead Sciences Inc. as a director in 1988 and in 1997 became Chairman.

Tamiflu was originally discovered by Gilead in 1998 and licensed to Roche for late-Phase development and marketing. In 1999, the FDA approved the use of the antiviral drug Tamiflu, developed by Gilead Sciences and Roche, for the treatment of flu (not just as a preventive drug).

Tamiflu is the only anti biotic that has shown effectiveness against the symptoms of the H5N1 bird-flu, however its efficacy against newer strains is questionable. 20 Tamiflu pills cost over $200. Mr. Rumsfeld still holds over $3 Million in Gilead Sciences stock.

Rumsfelds current stock holdings in Gilead

Rumsfelds Gilead Connection

Comments